Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)

Synonyms: MEDI 0562

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) is a human monoclonal antibody targeting TNFRSF4 (TNF receptor superfamily member 4) and OX40. It can be used in cancer immunology research. MW :146.36 KD.

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) is a human monoclonal antibody targeting TNFRSF4 (TNF receptor superfamily member 4) and OX40. It can be used in cancer immunology research. MW :146.36 KD.

Product Details

CAS No. 1635395-25-3
Molecular Weight 146.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) | Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) supplier | purchase Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) | Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) cost | Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) manufacturer | order Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) | Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) distributor